Vice versa, Wnt-pathway suppression restores DC infiltration, a phenomenon seen here upon therapy characterized by elevated levels of tumor-infiltrating CD11c+ DC that confirm successful therapy-related downregulation of the Wnt-pathway. Here, ITGAX is linked to neoplasm.